The pharmaceutical hub of Mumbai , India , has emerged as a significant center for the manufacture of Tetrabenazine API (CAS No. 58-46-8). Several established entities are dedicated to the production of this important active pharmaceutical ingredient. These firms often deliver Tetrabenazine to both the domestic and overseas markets, adhering to str